Duke University Medical Center Patient Treatment

Durham, North Carolina 27710

We've found

1 trials

at this facility

Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Durham, NC

Use our guide to learn which trials are right for you!